1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Argentina Pharmaceuticals and Healthcare Report Q2 2016

Argentina Pharmaceuticals and Healthcare Report Q2 2016

  • February 2016
  • -
  • Business Monitor International
  • -
  • 109 pages

Includes 3 FREE quarterly updates

BMI View: Over the next five years, Argentina's pharmaceutical and healthcare sector growth trends areexpected to substantially benefit from the improving business environment, including the liberalisation ofthe country's external accounts. Moreover, Argentina's geographical proximity, strong drug productionability and a skilled workforce will provide excellent investment opportunities for foreign drugmakers toexpand their presence in Latin America, including through local market leaders. Despite Argentina'sfavourable long-term growth outlook, short-term economic turbulence will negatively impact on returns inthe pharmaceutical and healthcare sector through the next few quarters, with higher investment returns topick up over a multi-year horizon.Headline Expenditure ProjectionsPharmaceuticals: ARS64.02bn (USD6.96bn) in 2015 to ARS79.27bn (USD5.47bn) in 2016; +23.8% inlocal currency terms and -21.4% in US dollar terms. Forecast revised upwards in local currency terms anddownwards in US dollar terms from last quarter.

Table Of Contents

Argentina Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceutical and Healthcare Forecasts (2014-2020) 7
SWOT 10
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Argentina 2012-2020) 15
Healthcare Market Forecast 16
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 22
Patented Drug Market Forecast 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 25
Generic Drug Market Forecast 26
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 28
OTC Medicines Forecast 29
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 31
Pharmaceutical Trade Forecast 32
Table: Pharmaceutical Trade Data And Forecasts (Argentina 2014-2020) 34
Table: Pharmaceutical Trade Data And Forecasts local currency (Argentina 2014-2020) 35
Industry Risk Reward Index 36
Americas Risk/Reward Index 36
Argentina Risk/Reward Index 42
Rewards 42
Risks 43
Regulatory Review 44
Table: Product Registration, Annex I and II Listed Countries 45
Intellectual Property Environment 52
Pricing Regime 56
Table: Pharmaceutical Price Build-Up 57
Reimbursement Regime 58
Market Overview 61
Healthcare Sector 62
Table: Healthcare Resources (Argentina 2010-2015) 65
Table: Healthcare Personnel (Argentina 2010-2015) 65
Table: Healthcare Activity (Argentina 2010-2015) 66
Research and Development 66
Clinical Trials 69
Epidemiology 70
Competitive Landscape 73
Research Based Industry 74
Table: Multinational Market Activity 78
Generic Drugmakers 79
Pharmaceutical Distribution 81
Pharmaceutical Retail Sector 81
Company Profile 85
GlaxoSmithKline 85
Laboratorios Bago 88
Novartis 92
Sanofi 95
Demographic Forecast 98
Table: Population Headline Indicators (Argentina 1990-2025) 99
Table: Key Population Ratios (Argentina 1990-2025) 99
Table: Urban/Rural Population and Life Expectancy (Argentina 1990-2025) 100
Table: Population By Age Group (Argentina 1990-2025) 100
Table: Population By Age Group % (Argentina 1990-2025) 101
Glossary 103
Methodology 105
Pharmaceutical Expenditure Forecast Model 105
Healthcare Expenditure Forecast Model 105
Notes On Methodology 106
Risk/Reward Index Methodology 107
Index Overview 108
Table: Pharmaceutical Risk/Reward Index Indicators 108
Indicator Weightings 109

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.